Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cns Pharmaceuticals Inc (NQ: CNSP )

1.840 -0.150 (-7.53%)
Streaming Delayed Price Updated: 3:58 PM EDT, May 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 171,662
Open 1.890
Bid (Size) 1.760 (2)
Ask (Size) 1.890 (3)
Prev. Close 1.990
Today's Range 1.830 - 1.974
52wk Range 0.6105 - 11.30
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Proton Beam Therapy Could Boost Quality of Life for Cancer Patients
Via Investor Brand Network
Topics Death
Exposures Death
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Achieves 50%+ Enrollment in Potentially Pivotal Berubicin Study
Via Investor Brand Network

Performance

YTD
-30.82%
-30.82%
1 Month
+8.24%
+8.24%
3 Month
+11.52%
+11.52%
6 Month
-70.79%
-70.79%
1 Year
-80.53%
-80.53%

More News

Read More
CNS Pharmaceuticals (NASDAQ:CNSP) Achieves Over 50% Completion of Enrollment in Potentially Pivotal Study with Berubicin for the Treatment of Glioblastoma Multiforme (GBM)
Via ACCESSWIRE
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Immix Biopharma Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Researchers Find New Way to Detect Brain Tumors Using Urine Tests
Via Investor Brand Network
Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
CNS Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
Via ACCESSWIRE
New Gel Cures Brain Tumors in Mice
Via Investor Brand Network
CNS Pharmaceuticals to Present at the Virtual Investor Spotlight Event - Rapidly Advancing GBM Pivotal Study
Via ACCESSWIRE
Notable Advancements Made in Research, Treatment of Brain Cancer
Via Investor Brand Network
Topics Death
Exposures Death
Why Monro Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Q1 2023 Results, Corporate Update
Via Investor Brand Network
Study Finds Possible Pathway to Prevent Brain Cancer Metastasis
Via Investor Brand Network
Researchers Use Genome Sequencing to Determine Genes That Trigger Familial Glioma
Via Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Board Appointment of Pharma and Biotech Industry Veteran Dr. Bettina M. Cockroft
Via Investor Brand Network
Bettina M. Cockroft, M.D., M.B.A., Pharmaceutical and Biotech Industry Veteran, Joins CNS Pharmaceuticals Board of Directors
Via ACCESSWIRE
EXCLUSIVE: Top 10 Most-Searched Tickers On Benzinga Pro In April, Including Tesla, First Republic Bank And Several AI Stocks
Via Benzinga
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Retains Analytics Firm, Investigates Possible Naked Short Selling
Via Investor Brand Network
Topics Law Enforcement
Exposures Legal
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
CNS Pharmaceuticals Investigating Potential Naked Short Selling; Retains Shareholder Intelligence Services, LLC
Via ACCESSWIRE
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Participate, Present at Upcoming Virtual Investor Spotlight Event
Via Investor Brand Network
Study Finds Traditional Chinese Medicine May Create New Way to Treat Brain Cancer
Via Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Advancing Potentially Pivotal Berubicin Trial
Via Investor Brand Network
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.